Vyriad, founded in 2016 by Mayo Clinic researchers to develop anti-cancer vaccines, recently moved from the Minnesota Biobusiness Center in downtown Rochester into 25,000 square feet of space in Building 110 on the Rochester Technology Campus, the former IBM campus, at 3605 U.S. Highway 52 North. While Vyriad’s team of about 20 employees is busy in the new offices and labs, work on the planned manufacturing facility is ongoing. While it is years before Vyriad could have a product or therapy on the market, the Rochester facility will produce the specialized viruses used in the clinical trials needed before becoming approved for general use. Learn More